![]() | Up a level |
Jain, Tania; Estrada-Merly, Noel; Salas, M Queralt; Kim, Soyoung; DeVos, Jakob D; Chen, Min; Fang, Xi; Kumar, Rajat; Andrade-Campos, Marcio; Elmariah, Hany; Agrawal, Vaibhav; Aljurf, Mahmoud; Bacher, Ulrike; Badar, Talha; Badawy, Sherif M; Ballen, Karen Kuhn; Beitinjaneh, Amer; Bhatt, Vijaya R; Bredeson, Christopher N; DeFilipp, Zachariah; ... (2024). Donor Types and Outcomes of Transplantation in Myelofibrosis: A CIBMTR Study. Blood advances, 8(16), pp. 4281-4293. American Society of Hematology 10.1182/bloodadvances.2024013451
Murthy, Hemant S; Zhang, Mei-Jie; Chen, Karen; Ahmed, Sairah; Deotare, Uday; Ganguly, Siddhartha; Kansagra, Ankit; Michelis, Fotios V; Nishihori, Taiga; Patnaik, Mrinal M; Abid, Muhammad Bilal; Aljurf, Mahmoud; Arai, Yasuyuki; Bacher, Vera; Badar, Talha; Badawy, Sherif M; Ballen, Karen; Battiwalla, Minoo; Beitinjaneh, Amer; Bejanyan, Nelli; ... (2023). Allogeneic Hematopoietic Cell Transplantation for Blastic Plasmacytoid Dendritic Cell Neoplasm: a CIBMTR analysis. Blood advances, 7(22), pp. 7007-7016. American Society of Hematology 10.1182/bloodadvances.2023011308
Boyiadzis, Michael; Zhang, Mei-Jie; Chen, Karen; Abdel-Azim, Hisham; Abid, Muhammad Bilal; Aljurf, Mahmoud; Bacher, Ulrike; Badar, Talha; Badawy, Sherif M; Battiwalla, Minoo; Bejanyan, Nelli; Bhatt, Vijaya Raj; Brown, Valerie I; Castillo, Paul; Cerny, Jan; Copelan, Edward A; Craddock, Charles; Dholaria, Bhagirathbhai; Perez, Miguel Angel Diaz; Ebens, Christen L; ... (2023). Correction to: Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113AML patients. Leukemia, 37(5), p. 1173. Springer Nature 10.1038/s41375-023-01814-2
Menghrajani, Kamal; Gomez-Arteaga, Alexandra; Madero-Marroquin, Rafael; Zhang, Mei-Jie; Bo-Subait, Khalid; Sanchez, Jonathan; Wang, Hai-Lin; Aljurf, Mahmoud; Assal, Amer; Bacher, Ulrike; Badawy, Sherif M; Bejanyan, Nelli; Bhatt, Vijaya Raj; Bredeson, Christopher N; Byrne, Michael; Castillo, Paul; Cerny, Jan; Chhabra, Saurabh; Ciurea, Stefan Octavian; DeFilipp, Zachariah; ... (2022). Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML. Blood advances, 6(3), pp. 828-847. American Society of Hematology 10.1182/bloodadvances.2021004881